NIDDK to Fund Type 2 Diabetes Genes Studies under Accelerating Medicines Partnership Program | GenomeWeb

NEW YORK (GenomeWeb) – The National Institutes of Health will provide $3 million in 2015 to fund research aimed at characterizing genetic variants associated with type 2 diabetes, NIH said on Friday. Researchers will use these awards, funded by the National Institute of Diabetes and Digestive and Kidney Diseases, to create the Accelerating Medicines Partnership T2D-GENES consortium.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.